Factor Therapeutic is ready to disclose the Phase II data.
A thrilling atmosphere surrounds thIs company. A flat lIne is ready to bIp for the first tIme. The EKG Is showImg the sIgn of a new lIfe.
So much tIme has passed sInce all started and so good has been VF001 for the clInIcal trIal patients, that now Is tIme to brIng thIs ptoject and the annexed pIpelIne to the market.